Immunologically reactive M. leprae antigens with relevance to diagnosis and vaccine development.
BACKGROUND
Leprosy is a chronic infectious disease caused by Mycobacterium leprae that can manifest a wide variety of immunological and clinical outcomes ranging from potent humoral responses among borderline lepromatous (BL) and lepromatous (LL) patients to strong cellular responses among tuberculoid (TT) and borderline tuberculoid (BT) patients. Until recently, relatively little has been known about the immune responses to individual proteins of M. leprae recognized during leprosy.


METHODS
The immune reactivity to a panel of 33 M. leprae recombinant proteins was evaluated among leprosy patients and controls from a high endemic area for leprosy (Goiania/GO, Central Brazil). Serum IgG responses were measured by ELISA (45 participants/group) and T cell responses (20 participants/group) were evaluated by IFN-gamma production in 24 hours whole blood cultures with antigen (whole blood assay-WBA). Study groups were newly diagnosed, untreated TT/BT and BL/LL leprosy patients classified by Ridley Jopling criteria and household contacts of BL/LL patients (HHC). Control groups were HIV-1 negative pulmonary tuberculosis patients (TB) and healthy individuals from the same endemic area (EC). In silico predictions indicated the level of identity of M. leprae proteins with homologues in other mycobacteria and the presence of T cell and B cell epitopes.


RESULTS
Despite the prediction that all proteins would be reactive, 16 of 33 (48%) of the single proteins tested were immunogenic (recognized in WBA or ELISA) and seventeen were non-immunogenic (not recognized in either assay). Among the 16 immunogenic proteins, 9 were considered leprosy specific in WBA inducing cell-mediated IFN-gamma secretion from TT/BT patients and HHC. Three of these proteins were also leprosy specific in serology being recognized by serum IgG from LL/BL patients. Seven of the immunogenic proteins were not leprosy specific.


CONCLUSIONS
New M. leprae antigens recognized by antibody responses of BL/LL patients and cellular responses of TT/BT leprosy patients were identified. An improved serological diagnostic test for leprosy could be developed by incorporating these IgG-reactive antigens to the current PGL-I based tests. Moreover our data indicate that the WBA is a robust, relatively simple and user friendly format for a T cell based diagnostic test. The field use of these test formats in leprosy endemic countries could contribute to early leprosy diagnosis before the development of deformities and disabilities.
Tropical Pathology and Public Health Institute, Federal University of Goiás, Goiânia, GO 74605050, Brazil.
Lucas H
LH
Sampaio
Mariane Ma
MM
Stefani
Regiane M
RM
Oliveira
Ana Lm
AL
Sousa
Greg C
GC
Ireton
Steven G
SG
Reed
Malcolm S
MS
Duthie
D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000907:Antibodies, Bacterial / Q000276:immunology; D000942:Antigens, Bacterial / Q000235:genetics / Q000276:immunology*; D001428:Bacterial Vaccines / Q000235:genetics / Q000276:immunology*; D005260:Female; D006801:Humans; D007918:Leprosy / Q000175:diagnosis* / Q000276:immunology* / Q000382:microbiology; D008297:Male; D008875:Middle Aged; D009166:Mycobacterium leprae / Q000235:genetics / Q000276:immunology*; D055815:Young Adult
D000907:Antibodies, Bacterial; D000942:Antigens, Bacterial; D001428:Bacterial Vaccines
Infect Immun. 2006 Jan;74(1):175-82
16368971
Clin Vaccine Immunol. 2008 Nov;15(11):1659-65
18784342
Infect Immun. 2000 Oct;68(10):5846-55
10992494
Proteins. 2006 Oct 1;65(1):40-8
16894596
Clin Vaccine Immunol. 2010 Jun;17(6):993-1004
20427628
Clin Vaccine Immunol. 2007 Nov;14(11):1400-8
17898185
Nature. 2001 Feb 22;409(6823):1007-11
11234002
Int J Lepr Other Mycobact Dis. 1966 Jul-Sep;34(3):255-73
5950347
Rev Soc Bras Med Trop. 2008;41 Suppl 2:89-94
19618083
Lepr Rev. 2008 Sep;79(3):242-53
19009974
Science. 1991 Oct 11;254(5029):277-9
1925582
Microbes Infect. 2006 Jul;8(8):2270-6
16797206
Wkly Epidemiol Rec. 2010 Aug 27;85(35):337-48
20830851
Clin Microbiol Rev. 2006 Apr;19(2):338-81
16614253
Hum Immunol. 2006 Jun;67(6):439-45
16728267
J Clin Microbiol. 2003 May;41(5):1991-5
12734239
Lepr Rev. 2005 Jun;76(2):147-59
16038248
Infect Immun. 2005 Sep;73(9):5636-44
16113281
Bioinformatics. 2003 May 22;19(8):1009-14
12761064
BMC Bioinformatics. 2009 May 08;10:136
19426475
Clin Vaccine Immunol. 2006 Mar;13(3):333-40
16522774
Clin Vaccine Immunol. 2009 Mar;16(3):352-9
19176694
J Immunol. 2005 Dec 15;175(12):7930-8
16339528
Acta Trop. 2009 Aug;111(2):172-6
19393609
Bull World Health Organ. 2005 Mar;83(3):230-5
15798849
Clin Vaccine Immunol. 2008 Mar;15(3):522-33
18199740